Organon & Co - Company Profile
Powered by 
All the sales intelligence you need on Organon & Co in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Organon & Co fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Organon & Co.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Organon & Co (Organon) develops and commercializes drugs for the treatment of women's health, dermatology, allergies, cardiovascular, respiratory, non-opioid pain and asthma.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Organon's R&D arm focuses on expanding its women's health and general medicines portfolios through scientific collaborations and acquisitions, particularly targeting later-stage or currently marketed assets. The company prioritizes financial flexibility to support clinical programs, especially in women's health, despite reducing some in-house R&D programs due to financial conditions. Organon's R&D efforts span the development lifecycle, emphasizing late-stage development, lifecycle management, and Phase 4 studies, supported by a team of seasoned researchers and medical experts. Organon's R&D organization supports products through global registration, pharmacovigilance, medical affairs, and health economics and outcomes research activities. The team includes OB/GYNs, PhDs, nurses, and pharmacists who contribute to understanding women's needs from various perspectives. Organon had licenses to commercialize several development-stage products, including OG-8012, OG-6219, OG-7191, and the Claria System. In FY2025, the company spent US$366 million on its R&D activities, which as a percentage of revenue stood at 5.9%. The company has also initiated a research collaboration and secured an exclusive license agreement with Cirqle Biomedical for a novel investigational non-hormonal contraceptive candidate. As per the agreement, Cirqle will conduct preclinical studies based on the mutually agreed research plan. The company has acquired exclusive worldwide rights for the development and commercialization of the product.
Product Categories
Overview
Areas of treatment include immunology and oncology. Distributes its products in more than 20 countries. The product portfolio includes Renflexis, Brenzys, Aybintio, Hadlima, and Ontruzant.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Disease areas include cardiovascular, dermatology, respiratory, and non-opioid pain management. Distributes its products in Canada, Colombia, Europe, Israel, South Korea, Kuwait, Mexico, Qatar, Saudi Arabia, Taiwan, Turkey, the US and the UAE. Brand portfolio includes Zetia, Singular, Propecia, Hyzaar, Atozet, Arcoxia, Diprospan and others.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes manufacturing sales to third parties.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes contraception and fertility drugs. Distributes its products in more than 90 markets including the US, Mexico, Canada, Brazil, Australia, China, Australia and many other countries in Asia, South America, European Union and Africa. The product portfolio includes Nexplanon/Implanon NXT, NuvaRing, Follistim AQ Catridge, Ganirelix Acetate Injection, Marvelon and Jada.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
- Asia Pacific and Japan
- China
- Europe and Canada
- Latin America, Middle East, Russia and Africa
- Other
- United States
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer